Han-Soo Keyoung
Director/Board Member at HUGEL, INC.
Profile
Dr. Han-Soo Keyoung is on the Board of Directors at Hugel, Inc. and I-Mab Bio-tech (Tianjin) Co. Ltd.
Dr. Keyoung was previously employed as a Co-Chief Executive Officer & Director by Genexine, Inc. He received his doctorate degree from Cornell University.
Han-Soo Keyoung active positions
| Companies | Position | Start |
|---|---|---|
| HUGEL, INC. | Director/Board Member | 2022-03-31 |
I-Mab Bio-tech (Tianjin) Co. Ltd.
 I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | Director/Board Member | - |
Former positions of Han-Soo Keyoung
| Companies | Position | End |
|---|---|---|
| GENEXINE, INC. | Chief Executive Officer | - |
Training of Han-Soo Keyoung
| Cornell University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GENEXINE, INC. | Health Technology |
| HUGEL, INC. | Health Technology |
| Private companies | 1 |
|---|---|
I-Mab Bio-tech (Tianjin) Co. Ltd.
I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | Health Technology |
- Stock Market
- Insiders
- Han-Soo Keyoung
